News Analysis
Among U.S. President Donald Trump’s election promises was to bring down prices for Americans, and the latest move, targeting pharmaceuticals, could result in Canadians having to pay more.
U.S. President Donald Trump (L), accompanied by Food and Drug Administration (FDA) Commissioner Martin Makary (2nd-L), and Health and Human Services Secretary Robert F. Kennedy Jr. (C), speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik/Getty Images
